Existing reports on the role of 17βHSD10 in astrocytes are predominantly theoretical, however they propose that the protein is upregulated in astrocytes surrounding amyloidogenic plaques, which might disrupt steroid metabolism in the brains of AD patients (He et al., 2005; He and Yang, 2006). Here, HSD17B10 is linked to Alzheimer disease.